262433-02-3

Basic information

• Product Name: 4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER
• Synonyms: tert-Butyl (2-Methoxy-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbaMate;4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER
• CAS NO: 262433-02-3
• Molecular Formula: C₁₈H₂₈BNO₅
• Molecular Weight: 349.23
• Product Categories: Heterocyclic Compounds
• Mol File: 262433-02-3.mol

Chemical Properties

• Boiling Point: 416.7°Cat760mmHg
• Flash Point: 205.8°C
• Appearance: /
• Density: 1.09g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.504
• PKA: 13.37±0.70(Predicted)
• CAS DataBase Reference: 4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER(262433-02-3)
• EPA Substance Registry System: 4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER(262433-02-3)

Safety Data

• Hazardous Substances Data: 262433-02-3(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER is used as a pharmaceutical intermediate for the synthesis of various bioactive compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Material Science:
In the field of material science, 4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER is utilized in the synthesis of advanced materials with specific properties, such as optical, electronic, or catalytic functions.
Used in Suzuki-Miyaura Cross-Coupling Reactions:
4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER is employed as a key reactant in Suzuki-Miyaura cross-coupling reactions, a widely used method for the formation of carbon-carbon bonds in organic synthesis. This reaction allows for the efficient construction of complex molecular structures and the synthesis of various organic compounds.
Used in Chemical Synthesis:
4-(TERT-BUTOXYCARBONYLAMINO)-3-METHOXYPHENYLBORONIC ACID, PINACOL ESTER is used as a versatile building block in diverse chemical syntheses, enabling the creation of a wide range of compounds with different functional groups and properties. Its unique structure and reactivity make it a valuable component in the synthesis of various organic and inorganic compounds.

InChI:InChI=1/C18H28BNO5/c1-16(2,3)23-15(21)20-13-10-9-12(11-14(13)22-8)19-24-17(4,5)18(6,7)25-19/h9-11H,1-8H3,(H,20,21)

Upstream product

• 73183-34-3 bis(pinacol)diborane 
• 262433-01-2 (4-bromo-2-methoxyphenyl)carbamic acid tert-butyl ester 
• 461699-81-0 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline 
• 24424-99-5 di-tert-butyl dicarbonate 
• 59557-91-4 4-bromo-2-methoxyaniline 

Downstream Products

• 330793-47-0 (4-{4-amino-1-[4-(4-methyl-piperazin-1-yl)-cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxy-phenyl)-carbamic acid tert-butyl ester 
• 832696-35-2 N-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-methyl-1H-indole-3-carboxamide 
• 330794-21-3 benzyl 4-(4-amino-3-{4-[(tert-butoxycarbonyl)amino]-3-methoxyphenyl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-1-piperidinecarboxylate 
• 1124330-11-5 benzyl 4-[3-methoxy-4-[(2-methylpropan-2-yl)oxycarbonyl-amino]phenyl]-3,6-dihydro-2H-pyridine-1-carboxylate 
• 1224708-53-5 tert-butyl N-[2-methoxy-4-(2-pyridyl)phenyl]carbamate 
• 1224708-46-6 tert-butyl 4-(4-(tert-butoxycarbonylamino)-3-methoxyphenyl)-5,6-dihydropyridine-1(2H)-carboxylate 
• 1224708-50-2 tert-butyl 4-(4-(tert-butoxycarbonylamino)-3-methoxyphenyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate 
• 262444-50-8 4-(4-amino-5-(4-amino-3-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanone 

Relevant articles and documents

Tyrosine Kinase Inhibitor And Uses Thereof

Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, or their stereoisomers, which can be used as tyrosine kinase inhibitor. Also disclosed is a method for preparing the compound, a pharmaceutical composition and a kit comprising the compound, and uses of the compound. The compound can be used as tyrosine kinase inhibitor, or can be used to reduce or inhibit activity of EGFR or mutant thereof, such as EGFR mutant comprising T790M mutation, in a cell, or to treat and/or prevent a disease associated with overactivity of EGFR, such as cancer.

Heterocyclic derivate tyrosine kinase inhibitor

The invention belongs to the technical field of medicine and particularly relates to a heterocyclic derivate tyrosine kinase inhibitor shown in the formula (I), a pharmaceutically acceptable salt and ester thereof and stereoisomers thereof, wherein Y, W, Q m, L, R1, R2, R3, R4, R5, R6, R7, R7', R8 and R8' are defined in the specification. The invention further relates to a preparation method of the compounds and a pharmaceutical preparation and pharmaceutical compositions containing the compounds, and application of the compounds as the tyrosine kinase inhibitor for preparing medicine for preventing and/or treating cancer diseases caused by EGFR mutation and drug resistance diseases caused by EGFR T790M mutation.

Preparation of Aminoaryl and Aminoheteroaryl Boronic Acids and Derivatives Thereof

The invention relates to a method for preparation of aminoaryl- or aminoheteroarylboronic acids and esters and salts thereof in which an optionally substituted aminoaryl or aminoheteroaryl compound is protected at its nitrogen site via condensation with a carbonyl compound, subsequently metalated and converted with a suitable boron compound. Depending on the subsequent work-up and removal of the protective group, the corresponding boronic acid, the anhydride or the boronic acid ester thereof is obtained

SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS

This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

Thienopyridine kinase inhibitors

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

Thienopyridine and furopyridine kinase inhibitors

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

Thienopyridine and furopyridine kinase inhibitors

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.